Earlier reports showed that the treatment of the colon cancer cell line HT29 with the differentiating agent sodium butyrate (NaBT) increased PTEN protein and mRNA expression and also induced c-Jun NH2-terminal kinase (JNK) activation. Here, MAPK8 is linked to colonic neoplasm.